WO2006064791A1 - Methods of producing ϝ-aminobutyric acid and extract containing ϝ-aminobutyric acid - Google Patents

Methods of producing ϝ-aminobutyric acid and extract containing ϝ-aminobutyric acid Download PDF

Info

Publication number
WO2006064791A1
WO2006064791A1 PCT/JP2005/022851 JP2005022851W WO2006064791A1 WO 2006064791 A1 WO2006064791 A1 WO 2006064791A1 JP 2005022851 W JP2005022851 W JP 2005022851W WO 2006064791 A1 WO2006064791 A1 WO 2006064791A1
Authority
WO
WIPO (PCT)
Prior art keywords
aminobutyric acid
acid
lactic acid
medium
yeast
Prior art date
Application number
PCT/JP2005/022851
Other languages
French (fr)
Japanese (ja)
Inventor
Masato Kawaguchi
Koujun Sato
Sachiko Tsuchiya
Hisae Matsunami
Rieko Hukayama
Isao Horiuchi
Original Assignee
Japan Applied Microbiology Research Institute Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Applied Microbiology Research Institute Ltd. filed Critical Japan Applied Microbiology Research Institute Ltd.
Priority to JP2006548850A priority Critical patent/JPWO2006064791A1/en
Publication of WO2006064791A1 publication Critical patent/WO2006064791A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids

Definitions

  • the present invention relates to a method for producing a novel ⁇ -aminobutyric acid and a ⁇ -aminobutyric acid-containing extract using lactic acid bacteria.
  • Patent Document 1 discloses such lactic acid bacteria as Lactobacillus casei (Lactobacillus casei), Lactobacillus bulgaricus (Lactobacillus bulgaricus), Lactobacillus helveticus, Lactobacillus helveticus (Lactobacillus helveticus), obacillus brevis) and the like.
  • Patent Document 1 JP 2001-120179 A
  • Patent Document 2 Japanese Patent Application Laid-Open No. 11-106276
  • an object of the present invention is to provide a novel method for producing a bis -aminobutyric acid and ⁇ -aminobutyric acid-containing extrude using lactic acid bacteria.
  • Lactobacillus reuteri (Lact obacillus reuteri), which is known as a lactic acid bacterium that produces Reuterin, which is a kind of antibacterial protein. It has been found that it has a much better ability to produce ⁇ -aminobutyric acid than lactic acid bacteria having the ability to produce ⁇ -aminobutyric acid.
  • ⁇ of the present invention was made based on the above findings - manufacturing method of Amino butyric acid as claimed in claim 1 Symbol placement, using Lactobacillus reuteri (Lactobacillus reuteri), glutamate or I from a salt thereof -A method for producing aminobutyric acid.
  • the method for producing a ⁇ -aminobutyric acid-containing extract of the present invention comprises a lactic acid bacterium containing at least Lactobacillus reuteri (Lactobacillus reuteri) in a medium containing gnoretamic acid or a salt thereof, as defined in claim 2.
  • This is a method for producing a ⁇ -aminobutyric acid-containing extract obtained by solid-liquid separation from a yeast coculture.
  • the method according to claim 3 is the method according to claim 2, wherein a medium containing soybean as a raw material is used as the medium containing glutamic acid or a salt thereof.
  • the ⁇ -aminobutyric acid-containing extract of the present invention comprises, as described in claim 4, lactic acid bacteria and yeast strains containing at least Lactobacillus reuteri in a medium containing glutamic acid or a salt thereof. It is obtained by solid-liquid separation from the cultivated culture.
  • the health food of the present invention comprises, as described in claim 5, the ⁇ -aminobutyric acid-containing extract according to claim 4 as an active ingredient.
  • the ⁇ -aminobutyric acid-containing composition of the present invention coexists with lactic acid bacteria and yeasts containing at least Lactobacillus reuteri in a medium containing glutamic acid or a salt thereof. It is obtained by culturing.
  • novel it using a lactic acid bacterium - may provide Amino acid-containing E manufacturing method kiss - Amino acid and I.
  • FIG. 1 is a graph showing the amount of ⁇ -aminobutyric acid in 100 ml of the culture supernatant of each of the 13 lactic acid bacteria strains in Example 1.
  • FIG. 2 shows the effect of adjusting the intestinal environment of the extract containing ⁇ -aminobutyric acid in Example 2 It is fu.
  • Lactobacillus reuteri that can be used in the present invention include, but are not limited to, a virulent strain including, for example, the strain of RIKEN Deposit Number JCM2762. .
  • y-aminobutyric acid is used to cultivate Lactobacillus reuteri (Lactobacillus reuteri) using a liquid medium for lactic acid bacteria to which, for example, gnoretamic acid or a salt thereof (sodium salt or the like) as a substrate is added. By doing so, it can be obtained from the culture solution.
  • the amount of glutamic acid or its salt added to the liquid medium for lactic acid bacteria is, for example, 0.2% (w / v) to 6.0% (w / v), preferably 0.5% (w / v) to 5.0% (w / v). v).
  • the liquid medium for lactic acid bacteria is a general medium used for liquid culture of lactic acid bacteria such as GYP medium.
  • sugars such as glucose, fructose, and maltose, yeast extract, polypeptone, sodium acetate, and various minerals can be used.
  • the culture conditions are, for example, a temperature of 25 ° C to 38 ° C, a culture time of 24 hours to 96 hours, and in particular, an optimum temperature of 37 ° C to 38 ° C and a stationary phase arrival time of 48 hours are desirable.
  • Acquisition of ⁇ -aminobutyric acid from the culture solution can be performed by a purification means such as liquid chromatography, membrane filtration, ultrafiltration, or nanofiltration.
  • ⁇ -aminobutyric acid is a lactobacillus reuteri (Lactobacillus reuteri) in various food materials (for example, soybeans described later) containing glutamic acid as a substrate or a salt thereof as a constituent component. It may be produced by inoculating and culturing.
  • the ⁇ _aminobutyric acid produced by the present invention can be used as a raw material for pharmaceuticals and health foods by a conventional method.
  • Lactobacillus reuteri contained in at least the lactic acid bacterium used in the present invention
  • the above-mentioned strain of RIKEN Deposit No. JCM2762 can be cited. It is not done.
  • Lactic acid bacteria In addition to Lactobacillus reuteri, for example, Ratatococcus' La , Lactobacillus acidophilus, Enterococcus faecalis, etc.
  • yeasts that can be used in the present invention include Saccharomyces cerevisiae (Saccharomyces cerevisiae).
  • Ir Carroses' Unis Hoffs Saccharomyces unisporus
  • Saccharomyces' Ma 1 ⁇ Ayue Saccharomyces martiniae
  • Tonorefus Hu '
  • the medium containing gnoretamic acid or a salt thereof may be any medium as long as it can cultivate both lactic acid bacteria and yeast.
  • Examples thereof include a culture medium containing soybean containing glutamic acid as a raw material.
  • Specific examples of the medium containing soybean as a raw material include those prepared by adding glucose or yeast extract to a powder obtained by crushing soybean.
  • Co-cultivation of lactic acid bacteria and yeast at least containing Lactobacillus reuteri in a medium containing glutamic acid or a salt thereof can be performed, for example, as follows. First, a lactic acid bacterium containing at least Lactobacillus reuteri is inoculated into a medium containing glutamic acid or a salt thereof and cultured. For example, inoculation may be performed at 0.5% to 2% (v / v) per bacterial species, for example, at 25 ° C to 45 ° C for 12 hours to 72 hours.
  • ⁇ -aminobutyric acid is produced from glutamic acid by the action of Lactobacillus reuteri.
  • the production of organic acids such as lactic acid and acetic acid lowers the ⁇ of the medium, making it suitable for culturing yeast. Therefore, the yeast is then inoculated into the medium (inoculation amount is 0.5% to 2% for example), and further cultured at 25 ° C to 45 ° C for 12 hours to 72 hours, for example.
  • ⁇ -aminobutyric acid is further produced from the glutamic acid produced by fermentation with yeast by the action of Lactobacillus reuteri.
  • lactic acid bacteria and yeasts containing at least Lactobacillus reuteri are pre-cultured using, for example, GYP medium and YM medium (for example, 10 6 ( ⁇ 1 ⁇ 1 ⁇ ⁇ 1)) and co-culture
  • GYP medium and YM medium for example, 10 6 ( ⁇ 1 ⁇ 1 ⁇ ⁇ 1)
  • YM medium for example, 10 6 ( ⁇ 1 ⁇ 1 ⁇ ⁇ 1)
  • multiple sets of lactic acid bacteria and yeast co-cultivation cultures (at least one co-cultivation culture is a lactic acid bacteria and yeast co-culture of at least Lactobacillus reuteri) May be mixed and further cultured in co-cultivation (mixing ratio is ex: '1: 0.5-1.5).
  • the ⁇ -aminobutyric acid-containing extract of the present invention can be obtained by, for example, solid-liquid separating a co-culture of lactic acid bacteria and yeast containing at least Lactobacill us reuteri by centrifugation or filtration. It can be obtained as the supernatant.
  • the ⁇ -aminobutyric acid-containing extract of the present invention can be used as a drink by adjusting the taste by adding it as it is or diluted with water, and adding acetic acid or citrate as necessary.
  • Example 1 Method for producing y-aminobutyric acid
  • Each component was mixed and dissolved in deionized water, and autoclaved at 121 ° C for 15 minutes, and a medium with sodium glutamate added to the GYP medium with the composition shown in Table 2 and Table 3 was used.
  • the main culture medium was centrifuged at 6000 rpm for 5 minutes, and separated into a centrifugal supernatant and bacterial cell precipitate.
  • Free amino acid analysis in the culture supernatant obtained as described above was performed according to a post-column system using high performance liquid chromatography (HPLC).
  • the analysis specimen used was a culture supernatant diluted 50-fold with 0.2 M citrate buffer (pH 2.2). If the culture supernatant is rich in protein, add 80% (v / v) ethanol and gently agitate to denature and aggregate the proteins, and then centrifuge them to remove them as precipitates. The centrifuged supernatant was diluted 50-fold with 0.2M citrate buffer (pH 2.2) to prepare an analytical sample. Analytes were filtered through a 0.2 zm filter and 20 ⁇ l was injected into the HPLC. The analysis conditions were as shown in Table 4.
  • Fig. 1 The amount of ⁇ -aminobutyric acid in 100 ml of the culture supernatant of each of the 13 lactic acid bacteria is shown in Fig. 1 (blank in the figure means the amount of ⁇ -aminobutyric acid in 100 ml of liquid medium not inoculated with lactic acid bacteria).
  • Fig. 1 the ability of Lactobacillus reuteri to produce ⁇ -aminobutyric acid is markedly superior to that of other lactic acid bacteria. It was.
  • Example 2 Method for producing ⁇ -aminobutyric acid-containing extract
  • Test strain Two combinations of the following two types of lactic acid bacteria and one type of yeast were used.
  • Lactic acid bacteria Lactobacillus reuteri (JCM2762)
  • Lactic acid bacteria Lattococus lactis (NBRC12007)
  • JCM1132 • Lactic acid bacteria: Enterococcus faecalis (NBRC14714)
  • GYP medium prepared by mixing and dissolving the components shown in Table 5 in deionized water was used.
  • YM medium prepared by mixing and dissolving the components shown in Table 6 in deionized water was used for preculture of yeast.
  • a soybean medium prepared by mixing and dissolving the components shown in Table 7 in deionized water was used for co-cultivation of lactic acid bacteria and yeast. All media were autoclaved at 121 ° C for 20 minutes before use.
  • Soybean powder 10.03 ⁇ 4 (w / v)
  • each lactic acid bacteria pre-culture solution for the combination 1 lactic acid bacteria and yeast inoculated in a 30 ° C incubator for 24 hours
  • the yeast preculture was inoculated with about 1% ( ⁇ / ⁇ ) of soybean medium, and further cultured for 48 hours in a 30 ° C incubator for co-cultivation.
  • Combination 2 lactic acid bacteria and yeast were cocultured in the same manner.
  • the desired co-cultivation culture was obtained by co-culturing
  • the co-cultured culture obtained as described above was autoclaved at 121 ° C for 20 minutes, and then centrifuged at 500 ° C. for 10 minutes to obtain a ⁇ -aminobutyric acid-containing extract as a centrifugal supernatant. .
  • the amount of amino acids contained in the ⁇ _aminobutyric acid-containing extract is shown in Table 8 together with the amount of amino acids contained in the soybean medium and the amount of amino acids contained in the supernatant of the combined lactic acid bacteria and yeast cultivated yeast. As is apparent from Table 8, it was found that the extract obtained by coculturing lactic acid bacteria and yeast containing Lactobacillus reuteri contained a large amount of ⁇ -aminobutyric acid.
  • the y-aminobutyric acid-containing extract was forcibly orally administered to mice for 14 days with a gastric sonde, and the aerobic intestinal bacteria in the stool were analyzed. Group and enterococci group) were compared.
  • the experimental method is as follows. Before the administration and on the 14th day after administration, fresh stool of mice was collected and weighed. After appropriately diluting the fecal sample with a diluent, each of the samples was added to the McConkey agar medium, which is a selective differentiation medium for coliforms, the LBS agar medium, which is a selective medium for lactic acid bacteria, and the EF agar medium, which is a selective medium for enterococci. / i Painted one by one.
  • the present invention relates to novel ⁇ -aminobutyric acid and ⁇ -aminobutyric acid-containing extract using lactic acid bacteria.
  • the present invention has industrial applicability in that a manufacturing method can be provided.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

[PROBLEMS] To provide novel methods of producing Ϝ-aminobutyric acid and an extract containing Ϝ-aminobutyric acid by using a lactic acid bacterium. [MEANS FOR SOLVING PROBLEMS] A method of producing Ϝ-aminobutyric acid which comprises using Lactobacillus reuteri and producing Ϝ-aminobutyric acid from glutamic acid or its salt. A method of producing an extract containing Ϝ-aminobutyric acid which comprises co-culturing lactic acid bacteria at least containing Lactobacillus reuteri together with a yeast in a medium containing glutamic acid or its salt and then obtaining an extract containing Ϝ-aminobutyric acid by subjecting the co-culture medium to solid-liquid separation.

Description

明 細 書  Specification
γ -ァミノ酪酸および γ -ァミノ酪酸含有エキスの製造方法  Method for producing γ-aminobutyric acid and γ-aminobutyric acid-containing extract
技術分野  Technical field
[0001] 本発明は、乳酸菌を用いた新規な γ -アミノ酪酸および γ -アミノ酪酸含有エキスの 製造方法に関する。  The present invention relates to a method for producing a novel γ-aminobutyric acid and a γ-aminobutyric acid-containing extract using lactic acid bacteria.
背景技術  Background art
[0002] 高血圧改善効果をはじめとする種々の薬理作用を有する γ -ァミノ酪酸(GABA)を 、グノレタミン酸またはその塩から産生する能力を有する乳酸菌が存在することは周知 の通りであり、例えば、特許文献 1には、そのような乳酸菌として、ラクトバチルス 'カゼ ィ (Lactobacillus casei)、ラク卜ノ チノレス *フノレガリカス (Lactobacillus bulgaricus;、ラク トバチルス 'ヘルべティカス(Lactobacillus helveticus)、ラクトバチルス'ブレビス(Lact obacillus brevis)などが記載されている。  [0002] It is well known that there are lactic acid bacteria having the ability to produce γ-aminobutyric acid (GABA) having various pharmacological actions including antihypertensive effect from gnoretamic acid or a salt thereof. Patent Document 1 discloses such lactic acid bacteria as Lactobacillus casei (Lactobacillus casei), Lactobacillus bulgaricus (Lactobacillus bulgaricus), Lactobacillus helveticus, Lactobacillus helveticus (Lactobacillus helveticus), obacillus brevis) and the like.
[0003] しかしながら、 γ _アミノ酪酸の産生能を有する乳酸菌のすべてが知られている訳で はなぐより優れた γ _ァミノ酪酸の産生能を有する乳酸菌の探索を行うことは意義深 レ、ことである。  [0003] However, not all lactic acid bacteria having the ability to produce γ_aminobutyric acid are known, but it is significant to search for a lactic acid bacterium having a better ability to produce γ_aminobutyric acid. It is.
[0004] また、近年、大豆を原料とした培地中での乳酸菌と酵母菌の共棲培養物から固液 分離して得られるエキスが、腸内環境を整える効果を有する健康食品などとして注目 されている(例えば特許文献 2を参照のこと)。  [0004] Also, in recent years, extracts obtained by solid-liquid separation from a cultivated lactic acid bacterium and yeast strain in a medium made from soybeans have attracted attention as health foods that have the effect of regulating the intestinal environment. (For example, see Patent Document 2).
[0005] し力、しながら、これまでに知られている乳酸菌と酵母菌の共棲培養エキスよりもより レ、つそう優れた効果を有するエキスが望まれてレ、る。 [0005] However, there is a demand for an extract having a much better effect than the previously known culturing extract of lactic acid bacteria and yeast.
特許文献 1 :特開 2001— 120179号公報  Patent Document 1: JP 2001-120179 A
特許文献 2:特開平 11一 106276号公報  Patent Document 2: Japanese Patent Application Laid-Open No. 11-106276
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0006] そこで本発明は、乳酸菌を用いた新規な Ί -ァミノ酪酸および γ -ァミノ酪酸含有ェ キスの製造方法を提供することを目的とする。 [0006] Accordingly, an object of the present invention is to provide a novel method for producing a bis -aminobutyric acid and γ-aminobutyric acid-containing extrude using lactic acid bacteria.
課題を解決するための手段 [0007] 本発明者らは、上記の点に鑑みて鋭意検討を重ねた結果、抗菌性タンパク質の一 種であるロイテリンを産生する乳酸菌として知られているラクトバチルス 'ロイテリ(Lact obacillus reuteri) これまでに知られている γ -ァミノ酪酸の産生能を有する乳酸菌 よりも遥かに優れた γ -ァミノ酪酸の産生能を有することを見出した。 Means for solving the problem [0007] As a result of intensive studies in view of the above points, the present inventors have found that Lactobacillus reuteri (Lact obacillus reuteri), which is known as a lactic acid bacterium that produces Reuterin, which is a kind of antibacterial protein. It has been found that it has a much better ability to produce γ-aminobutyric acid than lactic acid bacteria having the ability to produce γ-aminobutyric acid.
[0008] 上記の知見に基づいてなされた本発明の Ί -ァミノ酪酸の製造方法は、請求項 1記 載の通り、ラクトバチルス ·ロイテリ(Lactobacillus reuteri)を用いて、グルタミン酸また はその塩から Ί -ァミノ酪酸を製造する方法である。 [0008] Ί of the present invention was made based on the above findings - manufacturing method of Amino butyric acid as claimed in claim 1 Symbol placement, using Lactobacillus reuteri (Lactobacillus reuteri), glutamate or I from a salt thereof -A method for producing aminobutyric acid.
また、本発明の Ί -ァミノ酪酸含有エキスの製造方法は、請求項 2記載の通り、グノレ タミン酸またはその塩を含有する培地中でのラクトバチルス 'ロイテリ(Lactobacillus re uteri)を少なくとも含む乳酸菌と酵母菌の共棲培養物から固液分離して得る γ -ァミノ 酪酸含有エキスを製造する方法である。 In addition, the method for producing a Ί -aminobutyric acid-containing extract of the present invention comprises a lactic acid bacterium containing at least Lactobacillus reuteri (Lactobacillus reuteri) in a medium containing gnoretamic acid or a salt thereof, as defined in claim 2. This is a method for producing a γ-aminobutyric acid-containing extract obtained by solid-liquid separation from a yeast coculture.
また、請求項 3記載の方法は、請求項 2記載の方法において、グルタミン酸またはそ の塩を含有する培地として大豆を原料に含む培地を用いる。  The method according to claim 3 is the method according to claim 2, wherein a medium containing soybean as a raw material is used as the medium containing glutamic acid or a salt thereof.
また、本発明の γ -ァミノ酪酸含有エキスは、請求項 4記載の通り、グルタミン酸また はその塩を含有する培地中でのラクトバチルス 'ロイテリ(Lactobacillus reuteri)を少 なくとも含む乳酸菌と酵母菌の共棲培養物から固液分離して得られてなる。  In addition, the γ-aminobutyric acid-containing extract of the present invention comprises, as described in claim 4, lactic acid bacteria and yeast strains containing at least Lactobacillus reuteri in a medium containing glutamic acid or a salt thereof. It is obtained by solid-liquid separation from the cultivated culture.
また、本発明の健康食品は、請求項 5記載の通り、請求項 4記載の γ -ァミノ酪酸含 有エキスを有効成分とする。  The health food of the present invention comprises, as described in claim 5, the γ-aminobutyric acid-containing extract according to claim 4 as an active ingredient.
また、本発明の γ -ァミノ酪酸含有組成物は、請求項 6記載の通り、グルタミン酸また はその塩を含有する培地中でラクトバチルス 'ロイテリ(Lactobacillus reuteri)を少なく とも含む乳酸菌と酵母菌を共棲培養して得られてなる。  The γ-aminobutyric acid-containing composition of the present invention, as described in claim 6, coexists with lactic acid bacteria and yeasts containing at least Lactobacillus reuteri in a medium containing glutamic acid or a salt thereof. It is obtained by culturing.
発明の効果  The invention's effect
[0009] 本発明によれば、乳酸菌を用いた新規な Ί -ァミノ酪酸および Ί -ァミノ酪酸含有ェ キスの製造方法を提供することができる。 [0009] According to the present invention, novel it using a lactic acid bacterium - may provide Amino acid-containing E manufacturing method kiss - Amino acid and I.
図面の簡単な説明  Brief Description of Drawings
[0010] [図 1]実施例 1における乳酸菌 13株それぞれの培養上清 100ml中の γ -ァミノ酪酸量 を示すグラフである。  FIG. 1 is a graph showing the amount of γ-aminobutyric acid in 100 ml of the culture supernatant of each of the 13 lactic acid bacteria strains in Example 1.
[図 2]実施例 2における γ -ァミノ酪酸含有エキスの腸内環境を整える効果を示すダラ フである。 FIG. 2 shows the effect of adjusting the intestinal environment of the extract containing γ-aminobutyric acid in Example 2 It is fu.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0011] (1) γ _アミノ酪酸の製造方法  [0011] (1) Method for producing γ_aminobutyric acid
本発明において用いることができるラクトバチルス 'ロイテリ(Lactobacillus reuteri) の具体的な菌株としては、例えば、独立行政法人理化学研究所寄託番号 JCM2762 の菌株が挙げられる力 菌株はこれに限定される訳ではない。  Specific strains of Lactobacillus reuteri that can be used in the present invention include, but are not limited to, a virulent strain including, for example, the strain of RIKEN Deposit Number JCM2762. .
[0012] 本発明において、 y -ァミノ酪酸は、例えば、基質となるグノレタミン酸またはその塩( ナトリウム塩など)を添加した乳酸菌用液体培地を用いて、ラクトバチルス 'ロイテリ(La ctobacillus reuteri)を培養することで、その培養液から取得することができる。乳酸菌 用液体培地へのグルタミン酸またはその塩の添加量は、例えば、 0.2%(w/v)〜6.0%(w /v)であり、望ましくは 0.5%(w/v)〜5.0%(w/v)である。乳酸菌用液体培地は、 GYP培地 などの乳酸菌の液体培養に用いられる一般的なものであってよぐ例えば、ブドウ糖 や果糖や麦芽糖などの糖質、酵母エキス、ポリペプトン、酢酸ナトリウム、各種ミネラ ルを含むものが挙げられる。培養条件は、例えば、温度 25°C〜38°C、培養時間 24時 間〜 96時間であり、とりわけ、最適温度 37°C〜38°C、定常期到達時間 48時間に設定 することが望ましい。培養液からの γ -アミノ酪酸の取得は、例えば、液体クロマトダラ フィ一、メンブラン濾過、限外濾過、ナノ濾過などの精製手段によって行うことができ る。  [0012] In the present invention, y-aminobutyric acid is used to cultivate Lactobacillus reuteri (Lactobacillus reuteri) using a liquid medium for lactic acid bacteria to which, for example, gnoretamic acid or a salt thereof (sodium salt or the like) as a substrate is added. By doing so, it can be obtained from the culture solution. The amount of glutamic acid or its salt added to the liquid medium for lactic acid bacteria is, for example, 0.2% (w / v) to 6.0% (w / v), preferably 0.5% (w / v) to 5.0% (w / v). v). The liquid medium for lactic acid bacteria is a general medium used for liquid culture of lactic acid bacteria such as GYP medium.For example, sugars such as glucose, fructose, and maltose, yeast extract, polypeptone, sodium acetate, and various minerals can be used. Including. The culture conditions are, for example, a temperature of 25 ° C to 38 ° C, a culture time of 24 hours to 96 hours, and in particular, an optimum temperature of 37 ° C to 38 ° C and a stationary phase arrival time of 48 hours are desirable. . Acquisition of γ-aminobutyric acid from the culture solution can be performed by a purification means such as liquid chromatography, membrane filtration, ultrafiltration, or nanofiltration.
[0013] なお、本発明において、 γ -ァミノ酪酸は、基質となるグルタミン酸またはその塩を 構成成分として含む各種の食品素材 (例えば後述する大豆が挙げられる)に、ラクト バチルス 'ロイテリ (Lactobacillus reuteri)を接種して培養することによって製造しても よい。  In the present invention, γ-aminobutyric acid is a lactobacillus reuteri (Lactobacillus reuteri) in various food materials (for example, soybeans described later) containing glutamic acid as a substrate or a salt thereof as a constituent component. It may be produced by inoculating and culturing.
[0014] 本発明によって製造された γ _アミノ酪酸は、慣用的な方法で医薬品や健康食品の 原料として用いることができる。  [0014] The γ_aminobutyric acid produced by the present invention can be used as a raw material for pharmaceuticals and health foods by a conventional method.
[0015] (2) γ -ァミノ酪酸含有エキスの製造方法  [0015] (2) Method for producing γ-aminobutyric acid-containing extract
本発明において用いる乳酸菌に少なくとも含まれるラクトバチルス 'ロイテリ(Lactob acillus reuteri)の具体的な菌株としては、上述した独立行政法人理化学研究所寄託 番号 JCM2762の菌株が挙げられる力 S、菌株はこれに限定される訳ではない。乳酸菌 にはラクトバチルス.ロイテリ(Lactobacillus reuteri)の他に、例えば、ラタトコッカス 'ラ
Figure imgf000006_0001
、ラクトバチルス'ァシドフィルス(Lactobacillus acidophilu s〕、ェンテロコッカス'フエカリス(Enterococcus faecalis)などが含まれていてもよい。 また、本発明において用いることができる酵母菌としては、例えば、サッカロミセス- セレヒンェ (Saccharomyces cerevisiaeノ、 irッカロ セス 'ユニスホフス (Saccharomyces unisporus)、サッカロ セス 'マ1 ~アイユエ (Saccharomvces martiniae)、トノレフス 、フ'
Figure imgf000006_0002
これらは単独でまたは混 合して用いればよい。
As a specific strain of Lactobacillus reuteri contained in at least the lactic acid bacterium used in the present invention, the above-mentioned strain of RIKEN Deposit No. JCM2762 can be cited. It is not done. Lactic acid bacteria In addition to Lactobacillus reuteri, for example, Ratatococcus' La
Figure imgf000006_0001
, Lactobacillus acidophilus, Enterococcus faecalis, etc. Examples of yeasts that can be used in the present invention include Saccharomyces cerevisiae (Saccharomyces cerevisiae). , Ir Carroses' Unis Hoffs (Saccharomyces unisporus), Saccharomyces' Ma 1 ~ Ayue (Saccharomvces martiniae), Tonorefus, Hu '
Figure imgf000006_0002
These may be used alone or in combination.
[0017] グノレタミン酸またはその塩 (ナトリウム塩など)を含有する培地は、乳酸菌と酵母菌の 両方の培養が可能なものであればどのような培地であってもよレ、が、好適にはグルタ ミン酸を含有する大豆を原料に含む培地が挙げられる。大豆を原料に含む培地とし ては、大豆を破砕して得られる粉末にブドウ糖や酵母エキスなどを添加して調製した ものが具体的に例示できる。  [0017] The medium containing gnoretamic acid or a salt thereof (such as sodium salt) may be any medium as long as it can cultivate both lactic acid bacteria and yeast. Examples thereof include a culture medium containing soybean containing glutamic acid as a raw material. Specific examples of the medium containing soybean as a raw material include those prepared by adding glucose or yeast extract to a powder obtained by crushing soybean.
[0018] グルタミン酸またはその塩を含有する培地中でのラクトバチルス 'ロイテリ(Lactobaci llus reuteri)を少なくとも含む乳酸菌と酵母菌の共棲培養は、例えば、次のようにして 行うことができる。まず、ラクトバチルス 'ロイテリ(Lactobacillus reuteri)を少なくとも含 む乳酸菌をグルタミン酸またはその塩を含有する培地に接種して培養する。接種は、 例えば、 1菌種にっき 0.5%〜2% (v/v)で行えばよぐ培養は、例えば、 25°C〜45°Cで 1 2時間〜 72時間行えばよい。これにより乳酸菌による培地成分の発酵が進行し、ラクト バチルス.ロイテリ (Lactobacillus reuteri)の作用によりグルタミン酸から γ -ァミノ酪酸 が生成する。また、乳酸や酢酸などの有機酸が生成することで培地の ρΗが低下し、 酵母菌の培養に適した環境になる。そこで次に酵母菌を培地に接種し (接種量は例 ぇば1菌種にっき0.5%〜2% ))、さらに、例えば、 25°C〜45°Cで 12時間〜 72時間 培養を行う。これにより酵母菌による発酵により生成したグルタミン酸からラクトバチル ス.ロイテリ(Lactobacillus reuteri)の作用により γ -ァミノ酪酸がさらに生成する。なお 、ラクトバチルス 'ロイテリ(Lactobacillus reuteri)を少なくとも含む乳酸菌と酵母菌は、 共棲培養する前にそれぞれ、例えば、 GYP培地と YM培地を用いて前培養(1菌種に つき例えば 106(ΛαΑη1〜1θ ίΙιΑη1程度まで)しておくことが望ましい。また、共棲培養 をより効果的に行うために、複数組の乳酸菌と酵母菌の共棲培養物 (少なくとも 1つの 共棲培養物はラクトバチルス 'ロイテリ(Lactobacillus reuteri)を少なくとも含む乳酸菌 と酵母菌の共棲培養物である)を混合してさらに共棲培養してもよい(混合比率は例 免は' 1 :0.5〜1.5)。 [0018] Co-cultivation of lactic acid bacteria and yeast at least containing Lactobacillus reuteri in a medium containing glutamic acid or a salt thereof can be performed, for example, as follows. First, a lactic acid bacterium containing at least Lactobacillus reuteri is inoculated into a medium containing glutamic acid or a salt thereof and cultured. For example, inoculation may be performed at 0.5% to 2% (v / v) per bacterial species, for example, at 25 ° C to 45 ° C for 12 hours to 72 hours. As a result, fermentation of the medium components by lactic acid bacteria proceeds, and γ-aminobutyric acid is produced from glutamic acid by the action of Lactobacillus reuteri. In addition, the production of organic acids such as lactic acid and acetic acid lowers the ρΗ of the medium, making it suitable for culturing yeast. Therefore, the yeast is then inoculated into the medium (inoculation amount is 0.5% to 2% for example), and further cultured at 25 ° C to 45 ° C for 12 hours to 72 hours, for example. As a result, γ-aminobutyric acid is further produced from the glutamic acid produced by fermentation with yeast by the action of Lactobacillus reuteri. It should be noted that lactic acid bacteria and yeasts containing at least Lactobacillus reuteri are pre-cultured using, for example, GYP medium and YM medium (for example, 10 6 (ΛαΑη1˜ 1θ ίΙιΑη1)) and co-culture In order to make the treatment more effective, multiple sets of lactic acid bacteria and yeast co-cultivation cultures (at least one co-cultivation culture is a lactic acid bacteria and yeast co-culture of at least Lactobacillus reuteri) May be mixed and further cultured in co-cultivation (mixing ratio is ex: '1: 0.5-1.5).
[0019] 本発明の Ί -ァミノ酪酸含有エキスは、例えば、ラクトバチルス 'ロイテリ(Lactobacill us reuteri)を少なくとも含む乳酸菌と酵母菌の共棲培養物を遠心分離や濾過などに より固液分離することでその上清として得ることができる。本発明の Ί -ァミノ酪酸含有 エキスは、そのままや水で希釈し、必要に応じて酢酸やクェン酸などを添加して味覚 調整することでドリンクとして飲用することができる他、凍結乾燥した後、錠剤や顆粒 剤などに製剤化したり、粉末化したものを麵ゃパンなどに練り込んだりして食すること で、乳酸菌と酵母菌を共棲培養することにより得られる腸内環境を整える効果に加え 、 y -ァミノ酪酸の作用による高血圧改善効果などを有する健康食品として飲食する こと力 Sできる。なお、本発明の γ -ァミノ酪酸含有エキスを製造するための原料として 位置付けられるラクトバチルス 'ロイテリ(Lactobacillus reuteri)を少なくとも含む乳酸 菌と酵母菌の共棲培養物は、それ自体を γ _アミノ酪酸含有組成物として食すること あでさる。 [0019] The Ί -aminobutyric acid-containing extract of the present invention can be obtained by, for example, solid-liquid separating a co-culture of lactic acid bacteria and yeast containing at least Lactobacill us reuteri by centrifugation or filtration. It can be obtained as the supernatant. The -aminobutyric acid-containing extract of the present invention can be used as a drink by adjusting the taste by adding it as it is or diluted with water, and adding acetic acid or citrate as necessary. In addition to the effect of preparing the intestinal environment obtained by co-culturing lactic acid bacteria and yeast by formulating them into tablets or granules, or by kneading the powdered product into bread or the like. It is possible to eat and drink as a health food having the effect of improving hypertension due to the action of y-aminobutyric acid. In addition, the co-culture of lactic acid bacteria and yeast containing at least Lactobacillus reuteri, which is positioned as a raw material for producing the γ-aminobutyric acid-containing extract of the present invention, itself contains γ_aminobutyric acid. Eating as a composition
実施例  Example
[0020] 以下、本発明の γ -ァミノ酪酸および γ -アミノ酪酸含有エキスの製造方法について 実施例によってさらに詳細に説明するが、本発明は以下の記載に限定して解釈され るものではない。  [0020] Hereinafter, the method for producing γ-aminobutyric acid and γ-aminobutyric acid-containing extract of the present invention will be described in more detail with reference to Examples, but the present invention should not be construed as being limited to the following description.
[0021] 実施例 1: y -ァミノ酪酸の製造方法 Example 1: Method for producing y-aminobutyric acid
(A)乳酸菌の培養  (A) Culture of lactic acid bacteria
1.供試菌株  1. Test strain
株式会社応微研が保有する表 1に記載の乳酸菌 13株を用いた。  13 strains of lactic acid bacteria listed in Table 1 owned by Okenken Co., Ltd. were used.
[0022] [表 1] Lb.brevis (RIFY5111T) [0022] [Table 1] Lb.brevis (RIFY5111T)
Lb.casei (IF015883)  Lb.casei (IF015883)
Lb. fermentum (RIFY5127)  Lb. fermentum (RIFY5127)
Lb.helveticus W:  Lb.helveticus W:
Lb.plantarum (RIFY5 HOT: Type Strain)  Lb.plantarum (RIFY5 HOT: Type Strain)
Lb.reuteri (JCM2762)  Lb.reuteri (JCM2762)
Lc. lactis (NBRC12007)  Lc. Lactis (NBRC12007)
Stc. lactis (不明)  Stc. Lactis (unknown)
Stc. thermophilus (NBRC13957)  Stc. Thermophilus (NBRC13957)
Leuc.mesenteroides (RIFY5030T)  Leuc.mesenteroides (RIFY5030T)
Ped.pentosaceus (JCM5890)  Ped.pentosaceus (JCM5890)
Ec. faecal is (IAM10065)  Ec.faecal is (IAM10065)
Sib. inulinus (不明)  Sib. Inulinus (unknown)
く※) カツコ内は菌株の由来の保存機関管理番号を意味する。  *) In Katsuko, it means the storage organization control number from which the strain originates.
[0023] 2. γ-アミノ酪酸を製造するための乳酸菌用液体培地  [0023] 2. Liquid medium for lactic acid bacteria for producing γ-aminobutyric acid
各成分を脱イオン水に混合溶解し、 121°Cで 15分間オートクレープ滅菌して調製し た表 2と表 3に示す組成の GYP培地にグルタミン酸ナトリウムを添加した培地を用いた  Each component was mixed and dissolved in deionized water, and autoclaved at 121 ° C for 15 minutes, and a medium with sodium glutamate added to the GYP medium with the composition shown in Table 2 and Table 3 was used.
[0024] [表 2] [0024] [Table 2]
[0025]
Figure imgf000008_0001
[0025]
Figure imgf000008_0001
[0026] 3.前培養液の作製  [0026] 3. Preparation of preculture
予め画線培養した乳酸菌プレート上より 1白金耳コロニーを採取し、上記の液体培 地 30ml〜100mlに対して無菌的に接種した後、 37°Cのインキュベーター内で 1〜2日 間静置培養した。  Collect 1 platinum loop colony from a lactic acid bacteria plate that has been streaked in advance, and aseptically inoculate 30 ml to 100 ml of the above-mentioned liquid medium, and then leave it for 1 to 2 days in a 37 ° C incubator. did.
[0027] 4.本培養液の作製 [0027] 4. Preparation of the main culture
前培養した培養液を、本培養を行う液体培地に 1%(ν/ν)〜3%(ν/ν)接種し (これにより 前培養液を接種した本培養液の波長 600nm,光路程 10mmでの吸光度 ODは 0.01〜0. 02となる)、接種後、 37°Cのインキュベーター内で 4日間静置培養した。 [0028] 5.培養上清の分取 Inoculate 1% (ν / ν) to 3% (ν / ν) of the pre-cultured liquid medium into the liquid medium in which the main culture is performed. Absorbance OD was 0.01 to 0.02), and after inoculation, the cells were statically cultured in a 37 ° C incubator for 4 days. [0028] 5. Sorting of culture supernatant
本培養した培養液を 6000rpmで 5分間遠心分離を行い、遠心上清と菌体沈殿に分 離して得た。  The main culture medium was centrifuged at 6000 rpm for 5 minutes, and separated into a centrifugal supernatant and bacterial cell precipitate.
[0029] (B)培養上清のアミノ酸分析  [0029] (B) Amino acid analysis of culture supernatant
上記のようにして得た培養上清中の遊離アミノ酸分析を、高速液体クロマトグラフィ 一(HPLC)を用いてポストカラム方式に従って行った。分析検体は、培養上清を 0.2M クェン酸緩衝液 (pH2.2)にて 50倍希釈したものを用いた。培養上清がタンパク質に 富んでいる場合、 80%(v/v)エタノールを添加して穏やかに攪拌することでタンパク質 を変性'凝集させ、これらを遠心分離することで沈殿物として除去した後、遠心上清を 0.2Mクェン酸緩衝液 (pH2.2)にて 50倍希釈することで分析検体とした。分析検体は、 0.2 z mのフィルタで濾過した後に 20 μ 1を HPLCに注入した。なお、分析条件は表 4の 通りとした。  Free amino acid analysis in the culture supernatant obtained as described above was performed according to a post-column system using high performance liquid chromatography (HPLC). The analysis specimen used was a culture supernatant diluted 50-fold with 0.2 M citrate buffer (pH 2.2). If the culture supernatant is rich in protein, add 80% (v / v) ethanol and gently agitate to denature and aggregate the proteins, and then centrifuge them to remove them as precipitates. The centrifuged supernatant was diluted 50-fold with 0.2M citrate buffer (pH 2.2) to prepare an analytical sample. Analytes were filtered through a 0.2 zm filter and 20 μl was injected into the HPLC. The analysis conditions were as shown in Table 4.
[0030] [表 4]  [0030] [Table 4]
Figure imgf000009_0001
Figure imgf000009_0001
[0031] (C)結果  [0031] (C) Results
乳酸菌 13株それぞれの培養上清 100ml中の γ -ァミノ酪酸量を図 1に示す(図中 bla nkは乳酸菌を接種していない液体培地 100ml中の γ -ァミノ酪酸量を意味する)。図 1 力ら明らかなように、ラクトバチルス 'ロイテリ(Lactobacillus reuteri)の γ -ァミノ酪酸の 産生能は、他の乳酸菌の γ -ァミノ酪酸の産生能に比較して際立って優れていること がわかった。  The amount of γ-aminobutyric acid in 100 ml of the culture supernatant of each of the 13 lactic acid bacteria is shown in Fig. 1 (blank in the figure means the amount of γ-aminobutyric acid in 100 ml of liquid medium not inoculated with lactic acid bacteria). As can be seen in Fig. 1, the ability of Lactobacillus reuteri to produce γ-aminobutyric acid is markedly superior to that of other lactic acid bacteria. It was.
[0032] 実施例 2: γ -ァミノ酪酸含有エキスの製造方法  [0032] Example 2: Method for producing γ-aminobutyric acid-containing extract
(Α)乳酸菌と酵母菌の共棲培養  (Ii) Co-culture of lactic acid bacteria and yeast
1.供試菌株 以下に示す 2種類の乳酸菌と 1種類の酵母菌からなる組合せを 2組用いた。 1. Test strain Two combinations of the following two types of lactic acid bacteria and one type of yeast were used.
(組合せ 1)  (Combination 1)
•乳酸菌:ラクトバチルス ·ロイテリ(Lactobacillus reuteri: JCM2762)  • Lactic acid bacteria: Lactobacillus reuteri (JCM2762)
•乳酸菌:ラタトコッカス ·ラクテイス(Lactococus lactis: NBRC12007)  • Lactic acid bacteria: Lattococus lactis (NBRC12007)
•酵母菌:サッカロミセス ·マーティユエ (Saccharomyces martiniae: IFO0752)  • Yeast: Saccharomyces martiniae (IFO0752)
(組合せ 2)  (Combination 2)
'乳酸菌:ラクトバチルス'ァシドフィルス(Lactobacillus acidophilus :JCM1132) •乳酸菌:ェンテロコッカス'フエカリス(Enterococcus faecalis: NBRC14714)  'Lactobacillus acidophilus (JCM1132) • Lactic acid bacteria: Enterococcus faecalis (NBRC14714)
•酵母菌:サッカロミセス ·セレビ、ンェ (Saccharomyces cerevisiae: IFO0725)  • Yeast: Saccharomyces cerevisiae (IFO0725)
(¾ カツコ内末尾の番号は菌株の由来の保存機関管理番号を意味する。  (¾ The number at the end in Katsuko means the preservation agency control number from which the strain originates.
[0033] 2.使用培地  [0033] 2. Medium used
乳酸菌の前培養には表 5に示す成分を脱イオン水に混合溶解して調製した GYP培 地を用いた。酵母菌の前培養には表 6に示す成分を脱イオン水に混合溶解して調製 した YM培地を用いた。乳酸菌と酵母菌の共棲培養には表 7に示す成分を脱イオン水 に混合溶解して調製した大豆培地を用いた。なお、いずれの培地も 121°Cで 20分間 オートクレーブ滅菌してから用いた。  For pre-culture of lactic acid bacteria, GYP medium prepared by mixing and dissolving the components shown in Table 5 in deionized water was used. YM medium prepared by mixing and dissolving the components shown in Table 6 in deionized water was used for preculture of yeast. For co-cultivation of lactic acid bacteria and yeast, a soybean medium prepared by mixing and dissolving the components shown in Table 7 in deionized water was used. All media were autoclaved at 121 ° C for 20 minutes before use.
[0034] [表 5] ブドウ糖 ! 1.0¾(w/v)  [0034] [Table 5] Glucose! 1.0¾ (w / v)
酵母エキス i 0.5¾(w/v)  Yeast extract i 0.5¾ (w / v)
ポリペプトン ! 0.5¾(w/v)  Polypepton! 0.5¾ (w / v)
無水酢酸ナトリゥム • 0.5¾ ( /v)  Anhydrous sodium acetate • 0.5¾ (/ v)
無機塩溶液 0.25¾(w/v)  Inorganic salt solution 0.25¾ (w / v)
*) 表 3参照  *) See Table 3
[0035] :表 6]  [0035]: Table 6]
ブドウ糖 i 1.0¾(v/v)  Glucose i 1.0¾ (v / v)
酵母エキス 0.3¾(v/v)  Yeast extract 0.3¾ (v / v)
モルトエキス 0.3% (w/v)  Malt extract 0.3% (w / v)
ポリべプ卜ン i 0.5¾(w/v)  Polybepenne i 0.5¾ (w / v)
[0036] :翻 [0036] : Translation
大豆粉末 : 10.0¾(w/v)  Soybean powder: 10.0¾ (w / v)
ブドウ糖 1.0% (w/v)  Glucose 1.0% (w / v)
酵母エキス 1.0 (w/v)  Yeast extract 1.0 (w / v)
[0037] 3.前培養液の作製 凍結保存してぉレ、た乳酸菌をそれぞれ GYP培地に接種した後、 30°Cのインキュべ 一ター内で 24時間静置培養し、約 108cfli/mlの前培養液を作製した。同様に凍結保 存しておいた酵母菌をそれぞれ YM培地に接種し、 30°Cのインキュベーター内で 24 時間静置培養し、約 108cfu/mlの前培養液を作製した。 [0037] 3. Preparation of preculture After cryopreserving and inoculating the GYP medium with lees and lactic acid bacteria, they were statically cultured in a 30 ° C incubator for 24 hours to prepare a preculture solution of about 10 8 cfli / ml. Similarly, each of the yeasts that had been stored frozen was inoculated into YM medium, and left to stand for 24 hours in an incubator at 30 ° C. to prepare a preculture solution of about 10 8 cfu / ml.
[0038] 4.共棲培養物の作製 [0038] 4. Production of symbiotic culture
まず、組合せ 1の乳酸菌と酵母菌について、それぞれの乳酸菌前培養液を大豆培 地に対して約 1% (ν/ν)接種し、 30°Cのインキュベーター内で 24時間静置培養した後、 酵母菌前培養液を大豆培地に対して約 1% (ν/ν)接種し、 30°Cのインキュベーター内 でさらに 48時間静置培養することで共棲培養した。組合せ 2の乳酸菌と酵母菌につ いても同様にして共棲培養した。次に組合せ 1の乳酸菌と酵母菌の共棲培養物と組 合せ 2の乳酸菌と酵母菌の共棲培養物を 1 : 1の割合で混合し、さらに 30°Cのインキュ ベータ一内で 24時間静置培養することで共棲培養して目的とする共棲培養物を得た  First, about 1% (ν / ν) of each lactic acid bacteria pre-culture solution for the combination 1 lactic acid bacteria and yeast, inoculated in a 30 ° C incubator for 24 hours, The yeast preculture was inoculated with about 1% (ν / ν) of soybean medium, and further cultured for 48 hours in a 30 ° C incubator for co-cultivation. Combination 2 lactic acid bacteria and yeast were cocultured in the same manner. Next, combine the lactic acid bacteria and yeast co-culture of combination 1 with the lactic acid bacteria and yeast co-culture of combination 2 at a ratio of 1: 1, and let stand in an incubator at 30 ° C for 24 hours. By culturing, the desired co-cultivation culture was obtained by co-culturing
[0039] 5. γ -ァミノ酪酸含有エキスの分取 [0039] 5. Preparation of γ-aminobutyric acid-containing extract
上記のようにして得た共棲培養物を 121°Cで 20分間オートクレープ滅菌した後、 500 0卬 mで 10分間遠心分離を行レ、、 γ -ァミノ酪酸含有エキスを遠心上清として得た。  The co-cultured culture obtained as described above was autoclaved at 121 ° C for 20 minutes, and then centrifuged at 500 ° C. for 10 minutes to obtain a γ-aminobutyric acid-containing extract as a centrifugal supernatant. .
[0040] (Β) γ -ァミノ酪酸含有エキスのアミノ酸分析  [0040] (Β) Amino acid analysis of γ-aminobutyric acid-containing extract
上記のようにして得た γ -ァミノ酪酸含有エキス中の遊離アミノ酸分析を、実施例 1 の記載の方法と同様の方法で行った。  Analysis of free amino acids in the γ-aminobutyric acid-containing extract obtained as described above was carried out in the same manner as described in Example 1.
[0041] γ _アミノ酪酸含有エキスに含まれるアミノ酸量を、大豆培地に含まれるアミノ酸量と 組合せ 2の乳酸菌と酵母菌の共棲培養物の上清に含まれるアミノ酸量とともに表 8に 示す。表 8から明らかなように、ラクトバチルス ·ロイテリ(Lactobacillus reuteri)を含む 乳酸菌と酵母菌を共棲培養することで得られるエキスには γ -ァミノ酪酸が多量に含 まれていることがわかった。  [0041] The amount of amino acids contained in the γ_aminobutyric acid-containing extract is shown in Table 8 together with the amount of amino acids contained in the soybean medium and the amount of amino acids contained in the supernatant of the combined lactic acid bacteria and yeast cultivated yeast. As is apparent from Table 8, it was found that the extract obtained by coculturing lactic acid bacteria and yeast containing Lactobacillus reuteri contained a large amount of γ-aminobutyric acid.
[0042] [表 8] 大豆培地 ァ-ァミノ酪酸含有エキス 組合せ 2の上清 ァスパラギン酸 38.7 19.8 4.2 スレオニン 24.8 11.9 0.4 セリン 29.9 10.3 0.2 [0042] [Table 8] Soybean medium Aminobutyric acid-containing extract Combination 2 supernatant Aspartic acid 38.7 19.8 4.2 Threonine 24.8 11.9 0.4 Serine 29.9 10.3 0.2
グルタミン酸 71.3 11.0 5.5 グリシン 20.2 10.7 1.3 ァラニン 50.7 23.9 3.5 パリン 39.6 18.7 0.5  Glutamic acid 71.3 11.0 5.5 Glycine 20.2 10.7 1.3 Alanine 50.7 23.9 3.5 Parin 39.6 18.7 0.5
シスチン 1.6 0.3 未検出 メチォニン 10.0 3.9 0.2 イソロイシン 29.7 13.7 0.1 ロイシン 46.4 20.8 0.3 チロシン 10.8 5.0 0.4 フエニルァラニン 28.1 13.0 0.5 ヒスチジン 8.9 5.5 0.8 リジン 27.6 16.0 1.5  Cystine 1.6 0.3 Not detected Methionine 10.0 3.9 0.2 Isoleucine 29.7 13.7 0.1 Leucine 46.4 20.8 0.3 Tyrosine 10.8 5.0 0.4 Phenylalanine 28.1 13.0 0.5 Histidine 8.9 5.5 0.8 Lysine 27.6 16.0 1.5
トリブトファン 8.5 4.0 朱 出 アルギニン 49.8 「 0.9 0.7 プロリン 16.5 8.6 1.3 Tribute fan 8.5 4.0 Zhu out Arginine 49.8 0.9 0.9 Proline 16.5 8.6 1.3
7" -ァミノ酪酸 12.4 36.0 2.0 7 "-aminobutyric acid 12.4 36.0 2.0
単位: mg/100ml  Unit: mg / 100ml
[0043] (C) y -ァミノ酪酸含有エキスの腸内環境を整える効果 [0043] (C) Effect of y-aminobutyric acid-containing extract to improve intestinal environment
y -ァミノ酪酸含有エキスを胃ゾンデで 14日間マウスに強制経口投与し、糞便中の 好気性腸内細菌を分析することにより、投与前後での悪玉菌(主として大腸菌群)と 善玉菌(主として乳酸菌群と腸球菌群)の菌数を比較した。実験方法は次の通りであ る。投与前と投与 14日目にマウスの新鮮糞便を採取し、重量を測定した。糞便サンプ ルを希釈液にて適宜希釈後、大腸菌群の選択鑑別培地であるマッコンキー寒天培 地、乳酸菌群の選択培地である LBS寒天培地、腸球菌群の選択培地である EF寒天 培地にそれぞれ 20 /i 1づっ塗末した。 37°Cで 24〜48時間培養後コロニーをカウントし 、糞便重量あたりの菌数を算出した。その結果、善玉菌の指標とした乳酸菌群につ いては大きな変化はなかったが、腸球菌群については増加傾向、悪玉菌の指標とし た大腸菌群については減少傾向を示したことから、 γ -ァミノ酪酸含有エキスには腸 内環境を整える効果があることが確認できた(図 2参照)。  The y-aminobutyric acid-containing extract was forcibly orally administered to mice for 14 days with a gastric sonde, and the aerobic intestinal bacteria in the stool were analyzed. Group and enterococci group) were compared. The experimental method is as follows. Before the administration and on the 14th day after administration, fresh stool of mice was collected and weighed. After appropriately diluting the fecal sample with a diluent, each of the samples was added to the McConkey agar medium, which is a selective differentiation medium for coliforms, the LBS agar medium, which is a selective medium for lactic acid bacteria, and the EF agar medium, which is a selective medium for enterococci. / i Painted one by one. Colonies were counted after culturing at 37 ° C for 24-48 hours, and the number of bacteria per stool weight was calculated. As a result, there was no significant change in the lactic acid bacteria group that was an indicator of good bacteria, but there was an increasing tendency for the enterococci group and a decreasing tendency for the coliform group that was an indicator of bad bacteria. It was confirmed that the aminoaminobutyric acid-containing extract has an effect of adjusting the intestinal environment (see Fig. 2).
[0044] (D) y -ァミノ酪酸含有エキスの加工例(顆粒剤)  [0044] (D) Processing example of y-aminobutyric acid-containing extract (granule)
Ί -ァミノ酪酸含有エキスの凍結乾燥粉末 16g,澱粉 29g,乳糖 55g,合計 100gを均 一に混合し、常法に従って顆粒剤とした。  16 g of lyophilized powder of ァ -aminobutyric acid-containing extract, 29 g of starch, 55 g of lactose and 100 g in total were mixed uniformly, and granulated according to a conventional method.
産業上の利用可能性  Industrial applicability
[0045] 本発明は、乳酸菌を用いた新規な γ -アミノ酪酸および γ -アミノ酪酸含有エキスの 製造方法を提供することができる点において産業上の利用可能性を有する。 [0045] The present invention relates to novel γ-aminobutyric acid and γ-aminobutyric acid-containing extract using lactic acid bacteria. The present invention has industrial applicability in that a manufacturing method can be provided.

Claims

請求の範囲 The scope of the claims
[1] ラクトバチルス 'ロイテリ(Lactobacillus reuteri)を用いて、グルタミン酸またはその塩 から γ -ァミノ酪酸を製造する方法。  [1] A method for producing γ-aminobutyric acid from glutamic acid or a salt thereof using Lactobacillus reuteri.
[2] グルタミン酸またはその塩を含有する培地中でのラクトバチルス 'ロイテリ(Lactobaci llus reuteri)を少なくとも含む乳酸菌と酵母菌の共棲培養物から固液分離して得る Ί [2] Koji obtained by solid-liquid separation from a co-culture of lactic acid bacteria and yeast containing at least Lactobacillus reuteri in a medium containing glutamic acid or a salt thereof
-ァミノ酪酸含有エキスを製造する方法。 -Method for producing an aminoaminobutyric acid-containing extract.
[3] グノレタミン酸またはその塩を含有する培地として大豆を原料に含む培地を用いる請 求項 2記載の方法。 [3] The method according to claim 2, wherein a medium containing soybean as a raw material is used as the medium containing gnoretamic acid or a salt thereof.
[4] グルタミン酸またはその塩を含有する培地中でのラクトバチルス 'ロイテリ(Lactobaci llus reuteri)を少なくとも含む乳酸菌と酵母菌の共棲培養物から固液分離して得られ てなる γ -ァミノ酪酸含有エキス。  [4] γ-Aminobutyric acid-containing extract obtained by solid-liquid separation from a co-culture of lactic acid bacteria and yeast containing at least Lactobacillus reuteri (Lactobacillus reuteri) in a medium containing glutamic acid or a salt thereof .
[5] 請求項 4記載の γ -ァミノ酪酸含有エキスを有効成分とする健康食品。 [5] A health food comprising the γ-aminobutyric acid-containing extract according to claim 4 as an active ingredient.
[6] グルタミン酸またはその塩を含有する培地中でラクトバチルス 'ロイテリ(Lactobacilli! s reuteri)を少なくとも含む乳酸菌と酵母菌を共棲培養して得られてなる γ -アミノ酪 酸含有組成物。 [6] A γ-aminobutyric acid-containing composition obtained by co-culturing a lactic acid bacterium and yeast containing at least Lactobacilli reuteri (Lactobacilli! S reuteri) in a medium containing glutamic acid or a salt thereof.
PCT/JP2005/022851 2004-12-14 2005-12-13 Methods of producing ϝ-aminobutyric acid and extract containing ϝ-aminobutyric acid WO2006064791A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006548850A JPWO2006064791A1 (en) 2004-12-14 2005-12-13 Method for producing γ-aminobutyric acid and γ-aminobutyric acid-containing extract

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004361870 2004-12-14
JP2004-361870 2004-12-14

Publications (1)

Publication Number Publication Date
WO2006064791A1 true WO2006064791A1 (en) 2006-06-22

Family

ID=36587846

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/022851 WO2006064791A1 (en) 2004-12-14 2005-12-13 Methods of producing ϝ-aminobutyric acid and extract containing ϝ-aminobutyric acid

Country Status (2)

Country Link
JP (1) JPWO2006064791A1 (en)
WO (1) WO2006064791A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101805696A (en) * 2010-03-15 2010-08-18 胡峻 Method for culturing deodorized yeast and lactic acid bacteria simultaneously

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11106276A (en) * 1997-09-30 1999-04-20 Planning Shizuoka:Kk Useful composition comprising fermented product of soybean
JP2001120179A (en) * 1999-10-26 2001-05-08 Yakult Honsha Co Ltd Method for production of gaba-containing fermented milk
JP2001120288A (en) * 1999-10-29 2001-05-08 Yakult Honsha Co Ltd Method for producing lipid containing conjugated fatty acid glyceride and composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11106276A (en) * 1997-09-30 1999-04-20 Planning Shizuoka:Kk Useful composition comprising fermented product of soybean
JP2001120179A (en) * 1999-10-26 2001-05-08 Yakult Honsha Co Ltd Method for production of gaba-containing fermented milk
JP2001120288A (en) * 1999-10-29 2001-05-08 Yakult Honsha Co Ltd Method for producing lipid containing conjugated fatty acid glyceride and composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101805696A (en) * 2010-03-15 2010-08-18 胡峻 Method for culturing deodorized yeast and lactic acid bacteria simultaneously
CN101805696B (en) * 2010-03-15 2012-06-27 胡峻 Method for culturing deodorized yeast and lactic acid bacteria simultaneously

Also Published As

Publication number Publication date
JPWO2006064791A1 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
KR101950187B1 (en) Polybacterial preparation with health benefits: antioxidant effect, reduction of cholesterol concentration, anti-inflammatory immunomodulating effect and release of bioactive peptides inhibiting angiotensin-converting enzyme
CN1164761C (en) Process for producing product contg. antihypertensive tripeptides
TWI241912B (en) Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
US10603342B2 (en) Lactic acid bacteria for coeliac disease
JP5643285B2 (en) Production method of new Bifidobacterium
EP4053262A1 (en) Lactobacillus casei producing short-chain fatty acids, cultivation method therefor and application thereof
CN109517763B (en) Lactobacillus helveticus H11 and application thereof
Tung et al. Optimization of culture condition for ACEI and GABA production by lactic acid bacteria
CN110734880B (en) Lactobacillus plantarum Bama06 derived from Guangxi Bama and having high vitamin B yield and application thereof
JPWO2007097374A1 (en) Lactic acid bacteria having the ability to produce γ-aminobutyric acid
CN116396890B (en) Lactobacillus plantarum ZJUIDS15 for preventing and treating colon cancer and application thereof
CN115466705B (en) Lactobacillus helveticus fermentation product with high biological preservative property, and preparation method and application thereof
Ahtesh et al. Effects of fermented skim milk drink by Kluyveromyces marxianus LAF 4 co‐cultured with lactic acid bacteria to release angiotensin‐converting enzyme inhibitory activities
US11913047B2 (en) Method for producing γ-aminobutyric acid and fermented culture prepared thereby
TW201625282A (en) Novel Acetobacter and Gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
Bustos et al. Recent Advances in the Understanding of Stress Resistance Mechanisms in Probiotics: Relevance for the Design of Functional Food Systems
WO2006064791A1 (en) Methods of producing ϝ-aminobutyric acid and extract containing ϝ-aminobutyric acid
Vamanu et al. Influence of the culture medium composition on the exopolysaccharides synthesis by Streptococcus sp. IL5 strain
CN117757658B (en) Pediococcus pentosaceus from silkworm intestinal tract and application thereof
CN116804173B (en) Enterococcus avium with high gamma-aminobutyric acid yield and screening method and application thereof
TWI849332B (en) PROCESS FOR PRODUCING γ-AMINOBUTYRIC ACID AND FERMENTED CULTURE PRODUCED THEREFROM
KR101342791B1 (en) Lactobacillus casei lp1 strain producing 1,4-dihydroxy-2-naphthoic acid and its use
CN112538439B (en) Lactobacillus plantarum and application thereof in preparing plant coagulated yoghurt and improving intestinal bacterial facies
KHACHATRYAN et al. A STUDY OF LACTIC ACID BACTERIA AND PROSPECTS FOR THEIR APPLICATION.
JP2022130013A (en) Novel halophilic lactic acid bacteria and methods for producing recovering amino acid and food composition using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006548850

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05816483

Country of ref document: EP

Kind code of ref document: A1